Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression

Oncology Reports

Volumn 33, Issue 3, 2015, Pages 1057-1063

  Xu, Ling ^a   Wang, Ting ^a   Meng, Wen Ying ^a   Wei, Jue ^a   Ma, Jia Li ^a   Shi, Min ^a   Wang, Yu Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Invasion; Migration; Salinomycin

Indexed keywords

GELATINASE B; SALINOMYCIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; ANTINEOPLASTIC AGENT; JUND PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PROTEIN C JUN; PYRAN DERIVATIVE;

ANGIOGENESIS ASSAY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HCCLM3 CELL LINE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; METASTASIS INHIBITION; MHCC 97H CELL LINE; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; PROTO-ONCOGENE PROTEINS C-JUN; PYRANS;

EID: 84921671300     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3680     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011.
2. Belghiti J and Fuks D: Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer 1:71-82, 2012.
3. Fan ST: Hepatocellular carcinoma - resection or transplant? Nat Rev Gastroenterol Hepatol 9:732-737, 2012.
4. Raza A and Sood GK: Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol 20:4115-4127, 2014.
5. Feng K and Ma KS: Value of radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Gastroenterol 20:5987-5998, 2014.
6. Szkudlarek-Mikho M, Saunders RA, Yap SF, Ngeow YF and Chin KV: Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis. Biochem Biophys Res Commun 428:487-493, 2012.
7. García-Domenech R, Zanni R, Galvez-Llompart M and de Julián-Ortiz JV: Modeling anti-allergic natural compounds by molecular topology. Comb Chem High Throughput Screen 16:628-635, 2013.
8. Wang F, He L, Dai WQ, Xu YP, Wu D, Lin CL, Wu SM, Cheng P, Zhang Y, Shen M, Wang CF, Lu J, Zhou YQ, Xu XF, Xu L and Guo CY: Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PLoS One 7:e50638, 2012.
9. Wang F, Dai W, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Li J, Zheng Y, Lu J, Yang J, Zhu R, Zhang H, Zhou Y, Xu L and Guo C: The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PLoS One 9:e97414, 2014.
10. Al Dhaheri Y, Attoub S, Arafat K, Abuqamar S, Eid A, Al Faresi N and Iratni R: Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation. Biochim Biophys Acta 1830:3121-3135, 2013.
11. Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P and Mehrpour M: Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy 9:714-729, 2013.
12. Yesildal F, Aydin F, Deveci S, Tekin S, Aydin I, Mammadov R, Fermanli O, Avcu F, Acikel C and Ozgurtas T: Aspartame induces angiogenesis in vitro and in vivo models. Hum Exp Toxicol pii: 0960327114537535, Jun. 12, 2014 (Epub ahead of print).
13. Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, Ding ZB, Devbhandari RP, Huang XY, Qiu SJ, Shi YH, Dai Z, Yang XR, Yang GH and Fan J: CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52:183-196, 2010.
14. Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, Meyer LR, Sloan CA, Malladi VS, Roskin KM, Suh BB, Hinrichs AS, Clawson H, Zweig AS, Kirkup V, Fujita PA, Rhead B, Smith KE, Pohl A, Kuhn RM, Karolchik D, Haussler D and Kent WJ: ENCODE whole-genome data in the UCSC genome browser. Nucleic Acids Res 39(Database issue):D871-D875, 2011.
15. Chuang TW, Lee YC and Kim CH: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 18:1123-1125, 2004.
16. Hong S, Park KK, Magae J, Ando K, Lee TS, Kwon TK, Kwak JY, Kim CH and Chang YC: Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J Biol Chem 280:25202-25209, 2005.
17. Yeh MH, Kao ST, Hung CM, Liu CJ, Lee KH and Yeh CC: Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol Lett 184:204-210, 2009.
18. Wang SD, Chen BC, Kao ST, Liu CJ and Yeh CC: Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. BMC Complement Altern Med 14:26, 2014.
19. Hernandez JM, Floyd DH, Weilbaecher KN, Green PL and Boris-Lawrie K: Multiple facets of junD gene expression are atypical among AP-1 family members. Oncogene 27:4757-4767, 2008.
20. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL and Yang PC: Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68:7428-7438, 2008.